Clinical trial
ARIXTRA Local Study For Registration In China.
NCT00328939 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00328939 |
|---|---|
| Title | ARIXTRA Local Study For Registration In China. |
| Official title | Randomized, Single Blind, Parallel Study to Compare the Safety and Efficacy of ARIXTRA to Enoxaparine in Patients Undergoing Elective Major Hip or Knee Replacement or a Revision of Components. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Thromboembolism, Knee Replacement, Hip Replacement |
| Intervention type | Drug |
| Interventions | ARIXTRA infusion, Enoxaparine infusion |
| Enrollment | 240 |
| Start date | May 1, 2004 |
| First posted | May 24, 2006 |
| Last update posted | Jun 4, 2012 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: